Iron is both necessary for normal metabolism and a danger to homeostasis(1). Our preliminary studies suggest that iron is essential for normal responses to cytokine stimulation characteristic of cutaneous inflammatory responses. Previous studies examining cutaneous responses to LTV light also suggests a role for iron in induction of clinical erythema (2) as well as induction of proteinases linked to photoaging (3). Our hypothesis is that free intracellular iron in the ferrous state (Fe+2) is an important constituent of the cytokine mediating signaling cascade by participating in the generation of oxidative signaling intermediate that plays an important role in the activation of specific pro-inflammatory genes. The evidence for iron in the induction of inducible adhesion molecules in endothelial cells is indirect, relying on the use of iron chelating agents such as dipyridyl (DP). In order to define the pathways involved in the iron-dependent signaling pathways in endothelial cells, we will:
Specific aim 1 : Examine whether DP treatment alters the expression of intracellular free iron levels, intracellular reactive oxygen species in tumor necrosis factor alpha (TNFalpha)-treated human dermal microvascular endothelial cells (HDMEC) and whether these species are important in VCAM-1 gene expression.
Specific aim 2 : Examine whether DP pretreatment prior to TNF stimulation inhibits increases in steady-state VCAM-1 mRNA by altering mRNA stability and/or gene transcription.
Specific aim 3 : Examine whether DP treatment affects the expression of or phosphorylation of the transcription factors p65 or interferon regulatory factor 1 (IRF-1).

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Center Core Grants (P30)
Project #
5P30AR042687-08
Application #
6463606
Study Section
Special Emphasis Panel (ZAR1)
Project Start
1994-03-01
Project End
2004-04-30
Budget Start
Budget End
Support Year
8
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Emory University
Department
Type
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Arbiser, Jack L; Bonner, Michael Y; Gilbert, Linda C (2017) Targeting the duality of cancer. NPJ Precis Oncol 1:
Pleniceanu, Oren; Shukrun, Racheli; Omer, Dorit et al. (2017) Peroxisome proliferator-activated receptor gamma (PPAR?) is central to the initiation and propagation of human angiomyolipoma, suggesting its potential as a therapeutic target EMBO Mol Med 9:508-530
Díaz, Begoña; Ostapoff, Katherine T; Toombs, Jason E et al. (2016) Tris DBA palladium is highly effective against growth and metastasis of pancreatic cancer in an orthotopic model. Oncotarget 7:51569-51580
Laidlaw, Kamilla M E; Berhan, Samuel; Liu, Suhu et al. (2016) Cooperation of imipramine blue and tyrosine kinase blockade demonstrates activity against chronic myeloid leukemia. Oncotarget 7:51651-51664
Bhandarkar, Sulochana S; Lanka, Padmavathy; Lanka, Lakshmana Rao et al. (2016) Tuberculosis verrucosa cutis lesions exhibit a greater microvessel count than lupus vulgaris lesions. Exp Dermatol 25:479-80
Costa, Adilson; Bonner, Michael Yi; Arbiser, Jack L (2016) Use of Polyphenolic Compounds in Dermatologic Oncology. Am J Clin Dermatol 17:369-85
Bonner, Michael Y; Karlsson, Isabella; Rodolfo, Monica et al. (2016) Honokiol bis-dichloroacetate (Honokiol DCA) demonstrates activity in vemurafenib-resistant melanoma in vivo. Oncotarget 7:12857-68
Arbiser, Jack L; Bonner, Michael Y (2016) Seborrheic Keratoses: The Rodney Dangerfield of Skin lesions, and Why They Should Get Our Respect. J Invest Dermatol 136:564-566
Arbiser, Jack L (2014) PHIPing out: a genetic basis for tumor ulceration. J Invest Dermatol 134:600-602
Spence-Shishido, Allyson; Carr, Christopher; Bonner, Michael Y et al. (2013) In vivo Gram staining of tinea versicolor. JAMA Dermatol 149:991-2

Showing the most recent 10 out of 131 publications